NCT04950413

Brief Summary

General purpose: It was investigate the effect of IASTM and phonophoresis on Tension Type headache. Specific Purpose:

  1. 1.It was investigate the effect of IASTM on headache frequency, PPT, pain intensity, and functional disability on trigger points of tension type headache.
  2. 2.It was investigate the effect of Lidocaine phonophoresis on headache frequency, PPT, pain intensity and functional disability on trigger points of tension type headache.
  3. 3.It was investigate the effect of IASTM and Lidocaine phonophoresis on headache frequency, PPT, pain intensity, and functional disability on trigger points of tension type headache.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

June 28, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
Last Updated

July 6, 2021

Status Verified

July 1, 2021

Enrollment Period

3 months

First QC Date

June 28, 2021

Last Update Submit

July 2, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Assessing the change in pain intensity

    assessment via using visual analogue scale (VAS) most commonly consists of a 100mm horizontal line anchored with two opposite labels; patients mark a score on the scale using a vertical line. A VAS is easy to use and therefore applicable to a variety of practice and research settings. (0 means no pain \& 10 means highest pain intensity).

    Baseline and 4 weeks post-intervention

  • Assessing the change in neck disability

    assessment via using Neck disability index: The NDI can be scored as a raw score or doubled and expressed as a percent. Each section is scored on a 0 to 5 rating scale, in which zero means 'No pain' and 5 means 'Worst imaginable pain'. All the points can be summed to a total score. The test can be interpreted as a raw score, with a maximum score of 50, or as a percentage. 0 points or 0% means: no activity limitations, 50 points or 100% means complete activity limitation,Mean duration of the test: 3 to 7.8 minutes some benchmarks can be found in literature, Vernon and Moir presented the following interpretation: 0-4points (0-8%) no disability. 5-14points (10-28%) mild disability. 15-24points (30-48%) moderate disability. 25-34points (50-64%) severe disability. 35-50points (70-100%) complete disability.

    Baseline and 4 weeks post-intervention

  • Assessing the change in Pain Pressure Threshold

    assessment via using Pressure algometer: Pain Pressure Threshold (PPT) was measured by an algometer using a 1 cm2 disk surface area pressed vertically on MTrP. To provoke pain, pressure was increased with a speed of 1kg/cm2/s-1

    Baseline and 4 weeks post-intervention

  • Assessing the change in frequency of headache

    Headache frequency assessed after and before 12 sessions. It was defined as the number of headache days per week. The frequency of days with headache in the past weeks was registered by the participant

    Baseline and 4 weeks post-intervention

Study Arms (4)

Traditional Treatment Arm

ACTIVE COMPARATOR

conventional physical therapy program (infrared, stretching exercise, isometric strengthening exercise)

Other: Conventional physical therapy program

IASTM treatment arm

EXPERIMENTAL

Instrument-assisted soft tissue mobilization (IASTM) is a therapeutic technique that is based on the soft tissue mobilization rationale introduced by James Cyriax.

Other: Conventional physical therapy programOther: IASTM by M2t blade

Phonophoresis treatment arm

EXPERIMENTAL

It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2.

Other: Conventional physical therapy programDevice: Phonophoresis

Combined IASTM and phonophoresis treatment arm

EXPERIMENTAL

Combined phonophoresis and M2t Blade

Other: Conventional physical therapy programOther: IASTM by M2t bladeDevice: Phonophoresis

Interventions

Infrared, Exercises, Stretching exercise of Suboccepital muscle

Combined IASTM and phonophoresis treatment armIASTM treatment armPhonophoresis treatment armTraditional Treatment Arm

A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad. First, the M2T blade will used to find the exact areas of restriction in affected muscles. Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle. Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue. Once an adhesion is discovered, strokes are repeated for 5 min.

Combined IASTM and phonophoresis treatment armIASTM treatment arm

It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and. A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck. lidocine gelwill applied instead of coupling US gel used for transmission.

Combined IASTM and phonophoresis treatment armPhonophoresis treatment arm

Eligibility Criteria

Age30 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Their age ranged from 30 to 40 years.
  • BMI ranged from 18 to 25 kg /m2.
  • TTH criteria according to the Headache Classification Committee of the International Headache Society has at least two of the following characteristics:
  • Bilateral location.
  • Pressing/tightening quality (non-pulsating).
  • Mild or moderate intensity.
  • Not aggravated by routine physical activity such as walking or climbing stairs.
  • Patients have Trigger points in suboccipital muscle and trigger points 1 trapezius muscle.
  • The presence of MTrPs will be determined using the diagnostic criteria described by Simons 1990, in which five major criteria and at least one of three minor criteria are needed for a clinical diagnosis of MPS.

You may not qualify if:

  • Patients with a history of malignancy.
  • Patients who had a history of cervical and cranial Surgery.
  • Patients with major psychiatric disorders (major Depression).
  • Patients with uncontrolled hypertension
  • Patient with other causes of headache.
  • Dysfunctions in the temporomandibular joint.
  • Headaches associated with high fever, stiff neck, or rash, problems with vision, or profound dizziness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient clinic - Faculty of Physical Therapy - Cairo University

Dokki, 12611, Egypt

Location

MeSH Terms

Conditions

HeadacheTension-Type Headache

Interventions

Phonophoresis

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Prof Abeer Yamany, Professor

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Dr Mariam Omran, Lecturer

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor Investigator

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 6, 2021

Study Start

January 1, 2021

Primary Completion

April 1, 2021

Study Completion

May 30, 2021

Last Updated

July 6, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations